{
    "2019-02-25": [
        [
            {
                "time": "",
                "original_text": "【天风医药】一周医讯：继续看好后续医药板块行情，关注业绩高增长标的",
                "features": {
                    "keywords": [
                        "医药板块",
                        "业绩高增长",
                        "行情"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业: 两会政策决定医药产业走势, 政策免疫板块仍是首选",
                "features": {
                    "keywords": [
                        "医药生物",
                        "两会政策",
                        "政策免疫",
                        "板块"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}